-

Sirtex Medical Announces Acquisition of the FDA-Cleared Hourglass® Vascular Plug

Expands Sirtex’s embolization portfolio alongside the LAVA® Liquid Embolic System and reinforces its long-term commitment to advancing minimally invasive embolization therapies

WOBURN, Mass.--(BUSINESS WIRE)--Sirtex Medical (“Sirtex”), a leading manufacturer of interventional oncology and embolization solutions, today announced it has acquired the Hourglass embolization plug, an FDA 510(k)-cleared vascular plug indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature in vessels 6–8 mm in diameter.

Hourglass was previously introduced in the U.S. through a limited market release. Sirtex is completing the work needed to make the device available to physicians and will share availability details with customers.

“Dependable occlusion tools are central to treating a growing range of conditions with embolization. My experience with Hourglass was very positive, and I look forward to this device being available to physicians and their patients,” said Gary Siskin, M.D., FSIR, Professor and Chair of Radiology at Albany Medical Center.

“Behind every embolization procedure is a patient who benefits from a less invasive path to treatment,” said Matt Schmidt, Chief Executive Officer of Sirtex Medical. “Our investment in Hourglass is about making sure the physicians we work with have the right tools to deliver that care.”

About Hourglass
The Hourglass embolization plug is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature in vessels 6–8 mm in diameter. It initially received FDA 510(k) clearance in 2017.

About Sirtex
Sirtex Medical is a global healthcare company focused on advancing minimally invasive cancer and embolization therapies. With offices in the U.S., Australia, Europe and Asia, Sirtex delivers innovative interventional oncology and embolization solutions to physicians and patients worldwide. For more information, visit www.sirtex.com.

APM-US-004-11-26

Contacts

Jesse Hansen
Phone : 781-721-3880
Email : jesse.hansen@sirtex.com

Sirtex Medical


Release Summary
Sirtex Medical announces the acquisition of the FDA-cleared Hourglass® Vascular Plug, expanding its embolization portfolio.
Release Versions

Contacts

Jesse Hansen
Phone : 781-721-3880
Email : jesse.hansen@sirtex.com

Social Media Profiles
Back to Newsroom